Conclusion: Our data revealed that BMP9 might alleviate NAFLD via improving glucose and lipid metabolism, decreasing inflammatory response and reshaping chromatin accessibility in HFD mouse liver. This evidence concerns the gene GDF2 and metabolic dysfunction-associated steatotic liver disease.